Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
erzhu jiedu decoction
- Development stage
- Unknown
- Lead developer
- Shuguang Hospital
- Administration
- Oral
01
Overview
Erzhu Jiedu Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by Shuguang Hospital, which is affiliated with the Shanghai University of Traditional Chinese Medicine. It is primarily investigated for the treatment of advanced hepatitis B-associated hepatocellular carcinoma (HCC), specifically targeting the 'spleen deficiency and damp-heat' syndrome type. The decoction is typically administered orally in combination with standard antiviral therapies. Its therapeutic rationale involves addressing the underlying TCM pathological state to potentially inhibit tumor growth, improve liver function, and enhance the patient's quality of life.
- Other names
- Erzhu Jiedu Tang
Beyond the preview
Go deeper on erzhu jiedu decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on erzhu jiedu decoction.